Environmental enrichment ameliorates perinatal brain injury and promotes functional white matter recovery

Thomas A Forbes1,2, Evan Z Goldstein1, Jeffrey L Dupree3

  • 1Center for Neuroscience Research, Children's Research Institute, Children's National Hospital, Washington, DC, 20010, USA.

Nature Communications
|February 21, 2020
PubMed

Insights

Environmental enrichment aids brain repair in preterm infants by promoting white matter development and functional recovery. This approach enhances oligodendroglial maturation and myelination, offering a potential therapeutic strategy for neurological disabilities.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Regenerative Medicine

Background:

  • Preterm birth can cause hypoxic brain damage, leading to white matter abnormalities and lifelong cognitive/behavioral issues.
  • Environmental factors can improve neurological outcomes, but the cellular mechanisms are not fully understood.

Purpose of the Study:

  • To investigate how environmental enrichment influences brain repair after perinatal hypoxic injury.
  • To identify the cellular and molecular mechanisms underlying enrichment-induced recovery in the developing white matter.

Main Methods:

  • Utilized a model of perinatal hypoxic brain injury.
  • Applied early and continuous environmental enrichment (socialization, physical activity, cognitive stimulation).
  • Employed RNA-sequencing to analyze oligodendroglial responses and identify molecular pathways.

Main Results:

  • Environmental enrichment promoted oligodendroglial maturation and myelination in the developing white matter.
  • Enrichment led to significant functional recovery after hypoxic brain injury.
  • RNA-sequencing revealed oligodendroglial-specific responses to injury and identified key molecular mechanisms of enrichment-induced repair.

Conclusions:

  • Environmental enrichment is a potent therapeutic strategy for improving white matter repair and functional outcomes following preterm birth-related brain injury.
  • Myelin plasticity, modulated by the neonatal environment, represents a viable target for treating neurological deficits in preterm infants.